These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2386513)

  • 41. Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PD(Union) and G6PD(Andalus).
    Wang XT; Lam VM; Engel PC
    Hum Mutat; 2005 Sep; 26(3):284. PubMed ID: 16088936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Red cell enzymopathies as a model of inborn errors of metabolism.
    Miwa S; Kanno H; Hirono A; Fujii H
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():112-9. PubMed ID: 8629088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.
    Miwa S; Fujii H
    Am J Hematol; 1996 Feb; 51(2):122-32. PubMed ID: 8579052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human glucose-6-phosphate dehydrogenase: structure and function of normal and variant enzymes.
    Hirono A; Miwa S
    Haematologia (Budap); 1993; 25(2):85-97. PubMed ID: 8244203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneity of glucose-6-phosphate dehydrogenase enzymopathies in the CSSR.
    Jacobasch G; Sakalova A; Brabec V
    Biomed Biochim Acta; 1990; 49(2-3):S247-50. PubMed ID: 2386513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.